SoftBank Corp. and Intelsat Launch Landmark Collaboration to Create Ubiquitous Network
17.9.2024 02:00:00 CEST | Business Wire | Press release
SoftBank Corp. (“SoftBank”) and Intelsat signed a groundbreaking collaboration agreement that will lead to the launch of a single “Ubiquitous Network” enabling customers to stay connected everywhere they go. SoftBank and Intelsat will jointly lead research and development of seamless 5G connections between terrestrial mobile networks and satellite communications networks.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240916589802/en/
In a society where everyone and everything is increasingly dependent on staying connected, convenient, and always-on, telecommunications are essential. However, despite the coming realization of autonomous mobility with automobiles, ships, drones and other vehicles, many areas are still without ground-based mobile network coverage and require separate devices and accounts to connect to non-terrestrial networks.
Through the new collaboration, SoftBank and Intelsat plan to jointly develop a hybrid communication solution that allows users to stay connected via available networks, whether terrestrial or satellite, anywhere in the world with the convenience of one device and one account. The solution will build on the same standard architectures, interfaces and processes that enable roaming of devices between terrestrial cellular networks today and will help make the commercial adoption of mobility solutions based on new 3GPP 5G standards for non-terrestrial networks a reality much sooner.
One of the key goals of the collaboration is to develop a universal device that will always stay connected regardless of where in the world it goes. For example, a future connected vehicle equipped with such a device will be able to seamlessly switch to a non-terrestrial satellite communication network when outside of terrestrial mobile network coverage. The targeted solution is expected to have wide commercial applicability, including in land mobile, maritime, and disaster response and recovery.
Design, development, field testing and commercialization of new hybrid network products between Intelsat and SoftBank will be conducted in phases, aligned with the development of the new 3GPP 5G non-terrestrial network standards. The resulting hybrid solutions will allow for existing satellite terminals to be used in the near term and newer 5G-based terminals as they become available.
“Intelsat and SoftBank share a pioneering vision of Ubiquitous Networking and seamless interoperability between satellite and terrestrial networks,” said Bruno Fromont, Intelsat Chief Technology Officer. “Until now, the challenge was aligning standards that allowed the two different networks to connect. With recent progress on 5G-based standardization of non-terrestrial networks led by Intelsat at 3GPP and this strategic collaboration with SoftBank, we are ideally positioned to accelerate the design and practical implementation of commercial hybrid services that will allow devices to freely roam between satellite and terrestrial networks.”
Hideyuki Tsukuda, Executive Vice President and CTO of SoftBank said, "By using technology that switches between terrestrial mobile networks and satellite communication networks through roaming, we can integrate the two previously separate networks and utilize satellite communication as an extension of mobile communication. Through this joint research and development, SoftBank and Intelsat will aim to build a Ubiquitous Network where people and things around the world can be connected to communication anytime, anywhere."
About Intelsat
Intelsat’s global team of professionals is focused on providing seamless and secure, satellite-based communications to government, NGO and commercial customers through the company’s next-generation worldwide network and managed services. Bridging the digital divide by operating one of the world’s largest and most advanced satellite fleet and connectivity infrastructures, Intelsat enables people and their tools to speak over oceans, see across continents and listen through the skies to communicate, cooperate and coexist. Since its founding six decades ago, the company has been synonymous with satellite-industry “firsts” in service to its customers and the planet. Leaning on a legacy of innovation and focusing on addressing a new generation of challenges Intelsat team members now have their sights on the “next firsts” in space as they disrupt the field and lead in the digital transformation of the industry.
About SoftBank Corp.
Guided by the SoftBank Group’s corporate philosophy, “Information Revolution – Happiness for everyone,” SoftBank Corp. (TOKYO: 9434) operates telecommunications and IT businesses in Japan and globally. In the fiscal year ended March 2024, SoftBank Corp. registered 6,084.0 billion yen of revenue, 876.1 billion yen of operating income and 489.1 billion yen of net income. SoftBank Corp. has 40 million mobile subscribers in Japan, and through its group companies, 63 million smartphone payment (PayPay) users, 85 million online media (Yahoo! JAPAN) users and 97 million communication app (LINE) users (as of May 9, 2024). Building on its strong business foundation, SoftBank Corp. is expanding into non-telecom fields in line with its “Beyond Carrier” growth strategy while further growing its telecom business by harnessing the power of 5G/6G, IoT, Digital Twin and Non-Terrestrial Network (NTN) solutions, including High Altitude Platform Station (HAPS)-based stratospheric telecommunications. While constructing AI data centers and developing homegrown LLMs specialized for the Japanese language with 1 trillion parameters, SoftBank is applying AI to enhance radio access network performance (AI-RAN) with the aim of becoming a provider of next-generation social infrastructure. In recognition of its ESG initiatives, SoftBank Corp. was selected for inclusion in the Dow Jones Sustainability World Index (DJSI World) for 2022 and 2023, achieving the highest score in Japan and registering as the only company in the country to be selected for the Telecommunication Services industry group in 2023. To learn more, please visit https://www.softbank.jp/en/.
Follow Us on Social Media:
Twitter/X: https://twitter.com/INTELSAT
LinkedIn: https://www.linkedin.com/company/intelsat
Instagram: https://www.instagram.com/intelsat/?hl=en
YouTube: https://www.youtube.com/user/intelsatmedia
View source version on businesswire.com: https://www.businesswire.com/news/home/20240916589802/en/
Contacts
Melissa Longo - melissa.longo@intelsat.com; +1 240-308-1881
Melissa Longo - melissa.longo@intelsat.com; +1 240-308-1881
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom